Inhalable Dry Powder Formulations of siRNA and pH-Responsive Peptides with Antiviral Activity Against H1N1 Influenza Virus-Reference-Cited by-同舟云学术

Inhalable Dry Powder Formulations of siRNA and pH-Responsive Peptides with Antiviral Activity Against H1N1 Influenza Virus

Published:2015-01-30 Issue:3 Volume:12 Page:910-921
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Liang Wanling,Chow Michael Y. T.,Lau Pui Ngan,Zhou Qi Tony¹,Kwok Philip C. L.,Leung George P. H.,Mason A. James²,Chan Hak-Kim¹,Poon Leo L. M.,Lam Jenny K. W.

Affiliation:

1. Faculty of Pharmacy, University of Sydney, Sydney, NSW 2006, Australia

2. Institute of Pharmaceutical Science, King’s College London, 150 Stamford Street, London SE1 9NH, United Kingdom

Funder

Research Grants Council, University Grants Committee, Hong Kong

University of Hong Kong

National Health and Medical Research Council

University Grants Committee

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp500745v

Reference54 articles.

1. Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings

2. Reassortment of Pandemic H1N1/2009 Influenza A Virus in Swine

3. Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance

4. siRNA and the lung: research tool or therapeutic drug?

5. Inhibition of influenza virus production in virus-infected mice by RNA interference

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary Drug Delivery through Responsive Materials;Macromol;2024-07-11

2. Recent Progress in Nucleic Acid Pulmonary Delivery toward Overcoming Physiological Barriers and Improving Transfection Efficiency;Advanced Science;2024-03-09

3. PEGylated pH-responsive peptide-mRNA nano self-assemblies enhance the pulmonary delivery efficiency and safety of aerosolized mRNA;Drug Delivery;2023-06-19

4. Progress in non-viral localized delivery of siRNA therapeutics for pulmonary diseases;Acta Pharmaceutica Sinica B;2023-04

5. Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery;Journal of Controlled Release;2022-12